Pharmacokinetics and Safety of ORF Tablets in Pediatric Patients
| Status: | Archived |
|---|---|
| Conditions: | Hospital |
| Therapuetic Areas: | Other |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
| Start Date: | July 2010 |
| End Date: | June 2011 |
An Open-label Study to Characterize the Pharmacokinetics and Safety of Oxycodone Hydrochloride q12h Controlled-Release (ORF) Tablets in Pediatric Patients Aged 6 to 16 Years Inclusive, Who Require Opioid Analgesia
The purpose of this study is to characterize the pharmacokinetics (PK) of single-dose ORF
tablets in pediatric patients aged 6 to 16 years, inclusive.
We found this trial at
9
sites
725 Welch Road
Palo Alto, California 94304
Palo Alto, California 94304
Click here to add this to my saved trials
Children's Hospital - Boston Boston Children's Hospital is a 395-bed comprehensive center for pediatric health...
Click here to add this to my saved trials
Click here to add this to my saved trials
Children's Medical Center of Dallas Children's Medical Center is private, not-for-profit, and is the fifth-largest...
Click here to add this to my saved trials
Arkansas Children's Hospital Arkansas Children's Hospital (ACH) is the only pediatric medical center in Arkansas...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials